Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCLN
2626
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $522K | ﹤0.01% |
75,257
-344,675
| -82% | -$2.95M |
|
2627
Dana Inc
DAN
$3.24B
| $521K | ﹤0.01% |
32,817
-288,948
| -90% | -$5.22M |
|
2628
National Healthcare
NHC
$3.52B
| $520K | ﹤0.01% |
+8,539
| New | +$534K |
|
|
VWR
2629
DELISTED
VWR Corporation
VWR
| $518K | ﹤0.01% |
20,154
-46,351
| -70% | -$1.21M |
|
|
ATXS
2630
DELISTED
Astria Therapeutics
ATXS
| $517K | ﹤0.01% |
1,066
-181
| -15% | -$129K |
|
2631
Insight Enterprises
NSIT
$4.42B
| $516K | ﹤0.01% |
+19,961
| New | +$528K |
|
2632
Navigator Holdings
NVGS
$1.36B
| $516K | ﹤0.01% |
38,658
+8,158
| +27% | +$135K |
|
2633
Immersion
IMMR
$254M
| $514K | ﹤0.01% |
45,743
-7,857
| -15% | -$95.3K |
|
|
DTLK
2634
DELISTED
Datalink Corp
DTLK
| $513K | ﹤0.01% |
85,956
+42,407
| +97% | +$275K |
|
2635
Triumph Financial Inc
TFIN
$1.76B
| $512K | ﹤0.01% |
+30,498
| New | +$438K |
|
|
AAN.A
2636
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $512K | ﹤0.01% |
14,169
-123,152
| -90% | -$4.45M |
|
|
AFH
2637
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
| $511K | ﹤0.01% |
+27,606
| New | +$494K |
|
2638
MannKind Corp
MNKD
$1.34B
| $506K | ﹤0.01% |
+31,556
| New | +$670K |
|
2639
Fastenal
FAST
$57.7B
| $505K | ﹤0.01% |
+55,200
| New | +$547K |
|
2640
iShares US Technology ETF
IYW
$24.8B
| $505K | ﹤0.01% |
20,416
-24,808
| -55% | -$641K |
|
2641
Invesco Next Gen Media and Gaming ETF
GGME
$45.1M
| $503K | ﹤0.01% |
+21,015
| New | +$538K |
|
2642
KB Financial Group
KB
$42.4B
| $503K | ﹤0.01% |
17,100
+9,791
| +134% | +$297K |
|
|
CKH
2643
DELISTED
Seacor Holdings Inc.
CKH
| $503K | ﹤0.01% |
+8,696
| New | +$534K |
|
2644
Omnicom Group
OMC
$24.2B
| $501K | ﹤0.01% |
7,600
-23,926
| -76% | -$1.68M |
|
|
MOBL
2645
DELISTED
MobileIron, Inc.
MOBL
| $499K | ﹤0.01% |
160,870
-45,968
| -22% | -$211K |
|
|
MHR
2646
DELISTED
MAGNUM HUNTER RESOURCES CORP (DEL)
MHR
| $499K | ﹤0.01% |
1,467,459
+1,456,559
| +13,363% | +$1.34M |
|
2647
Culp Inc
CULP
$44.3M
| $498K | ﹤0.01% |
15,544
-43,426
| -74% | -$1.37M |
|
|
QIWI
2648
DELISTED
QIWI PLC
QIWI
| $497K | ﹤0.01% |
+30,815
| New | +$754K |
|
2649
Merck
MRK
$386B
| $494K | ﹤0.01% |
10,480
-753,481
| -99% | -$40M |
|
|
IQNT
2650
DELISTED
Inteliquent, Inc.
IQNT
| $494K | ﹤0.01% |
22,131
-50,150
| -69% | -$953K |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.